Differences in ethanol ingestion between cholecystokinin-A receptor deficient and -B receptor deficient mice. 2005

Kyoko Miyasaka, and Hiroko Hosoya, and Saeko Takano, and Minoru Ohta, and Ayako Sekime, and Setsuko Kanai, and Toshimitsu Matsui, and Akihiro Funakoshi
Department of Clinical Physiology, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan. miyasaka@tmig.or.jp

OBJECTIVE Cholecystokinin (CCK) modulates dopamine release in the nucleus accumbens through the CCK-A receptor (CCK-AR). The dopaminergic neurotransmission between the ventral tegmental area and the limbic forebrain is a critical neurobiological component of alcohol and drug self-administration. Based on the evidence of interaction between CCK and dopamine, we had found previously that the CCK-AR gene -81A/G polymorphism was associated with alcohol dependence. Since the precise mechanism underlying this association has not been elucidated, the role of CCK-AR in ethanol ingestion was examined using CCK-AR gene deficient (-/-) mice and compared with those of CCK-BR(-/-) and wild-type mice. METHODS The two-bottle choice protocol was conducted and the righting reflex was examined in these three genotypes. Furthermore, the protein level of dopamine 2 receptor (D2R) in the nucleus accumbens was determined by western blotting. RESULTS CCK-AR(-/-) mice consumed more ethanol than CCK-BR(-/-) and wild-type mice, and showed no aversion to high concentrations of ethanol solution. However, the difference was actually in the total fluid consumption and alcohol preference remained unchanged, indicating that the differences were not specific to alcohol. Behavioral sensitivity to ethanol, examined using the righting reflex, did not differ significantly between the groups. D2R expression in the nucleus accumbens was significantly lower in the CCK-BR(-/-) mice and was significantly higher in CCK-AR(-/-) mice than in wild-type mice. CONCLUSIONS Voluntary ingestion of ethanol differed between CCK-AR(-/-) and CCK-BR(-/-) mice. The difference might be attributable in part to the different levels of D2R expression in the nucleus accumbens.

UI MeSH Term Description Entries
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D009714 Nucleus Accumbens Collection of pleomorphic cells in the caudal part of the anterior horn of the LATERAL VENTRICLE, in the region of the OLFACTORY TUBERCLE, lying between the head of the CAUDATE NUCLEUS and the ANTERIOR PERFORATED SUBSTANCE. It is part of the so-called VENTRAL STRIATUM, a composite structure considered part of the BASAL GANGLIA. Accumbens Nucleus,Nucleus Accumbens Septi,Accumbens Septi, Nucleus,Accumbens Septus, Nucleus,Accumbens, Nucleus,Nucleus Accumbens Septus,Nucleus, Accumbens,Septi, Nucleus Accumbens,Septus, Nucleus Accumbens
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D000428 Alcohol Drinking Behaviors associated with the ingesting of ALCOHOLIC BEVERAGES, including social drinking. Alcohol Consumption,Alcohol Intake,Drinking, Alcohol,Alcohol Drinking Habits,Alcohol Drinking Habit,Alcohol Intakes,Consumption, Alcohol,Drinking Habit, Alcohol,Habit, Alcohol Drinking,Habits, Alcohol Drinking,Intake, Alcohol
D000431 Ethanol A clear, colorless liquid rapidly absorbed from the gastrointestinal tract and distributed throughout the body. It has bactericidal activity and is used often as a topical disinfectant. It is widely used as a solvent and preservative in pharmaceutical preparations as well as serving as the primary ingredient in ALCOHOLIC BEVERAGES. Alcohol, Ethyl,Absolute Alcohol,Grain Alcohol,Alcohol, Absolute,Alcohol, Grain,Ethyl Alcohol
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D017448 Receptors, Dopamine D2 A subfamily of G-PROTEIN-COUPLED RECEPTORS that bind the neurotransmitter DOPAMINE and modulate its effects. D2-class receptor genes contain INTRONS, and the receptors inhibit ADENYLYL CYCLASES. Dopamine D2 Receptors,Dopamine-D2 Receptor,D2 Receptors, Dopamine,Dopamine D2 Receptor,Receptor, Dopamine-D2
D043886 Receptor, Cholecystokinin A A subtype of cholecystokinin receptor found primarily in the PANCREAS; STOMACH; INTESTINE; and GALLBLADDER. It plays a role in regulating digestive functions such as gallbladder contraction, pancreatic enzyme secretion and absorption in the GASTROINTESTINAL TRACT. CCK-A Receptor,Cholecystokinin A Receptor,CCK(1) Receptor,CCK A Receptor,Receptor, CCK-A

Related Publications

Kyoko Miyasaka, and Hiroko Hosoya, and Saeko Takano, and Minoru Ohta, and Ayako Sekime, and Setsuko Kanai, and Toshimitsu Matsui, and Akihiro Funakoshi
May 2024, Alzheimer's research & therapy,
Kyoko Miyasaka, and Hiroko Hosoya, and Saeko Takano, and Minoru Ohta, and Ayako Sekime, and Setsuko Kanai, and Toshimitsu Matsui, and Akihiro Funakoshi
January 1997, Gastroenterology,
Kyoko Miyasaka, and Hiroko Hosoya, and Saeko Takano, and Minoru Ohta, and Ayako Sekime, and Setsuko Kanai, and Toshimitsu Matsui, and Akihiro Funakoshi
December 2006, The journal of physiological sciences : JPS,
Kyoko Miyasaka, and Hiroko Hosoya, and Saeko Takano, and Minoru Ohta, and Ayako Sekime, and Setsuko Kanai, and Toshimitsu Matsui, and Akihiro Funakoshi
June 2003, Pharmacogenetics,
Kyoko Miyasaka, and Hiroko Hosoya, and Saeko Takano, and Minoru Ohta, and Ayako Sekime, and Setsuko Kanai, and Toshimitsu Matsui, and Akihiro Funakoshi
May 2009, Neuroreport,
Kyoko Miyasaka, and Hiroko Hosoya, and Saeko Takano, and Minoru Ohta, and Ayako Sekime, and Setsuko Kanai, and Toshimitsu Matsui, and Akihiro Funakoshi
March 2007, Endocrinology,
Kyoko Miyasaka, and Hiroko Hosoya, and Saeko Takano, and Minoru Ohta, and Ayako Sekime, and Setsuko Kanai, and Toshimitsu Matsui, and Akihiro Funakoshi
April 2002, Naunyn-Schmiedeberg's archives of pharmacology,
Kyoko Miyasaka, and Hiroko Hosoya, and Saeko Takano, and Minoru Ohta, and Ayako Sekime, and Setsuko Kanai, and Toshimitsu Matsui, and Akihiro Funakoshi
January 2004, Journal of neural transmission. Supplementum,
Kyoko Miyasaka, and Hiroko Hosoya, and Saeko Takano, and Minoru Ohta, and Ayako Sekime, and Setsuko Kanai, and Toshimitsu Matsui, and Akihiro Funakoshi
November 2017, American journal of physiology. Regulatory, integrative and comparative physiology,
Kyoko Miyasaka, and Hiroko Hosoya, and Saeko Takano, and Minoru Ohta, and Ayako Sekime, and Setsuko Kanai, and Toshimitsu Matsui, and Akihiro Funakoshi
September 1985, Neuropeptides,
Copied contents to your clipboard!